FDA — authorised 1 November 1974
- Application: NDA009238
- Marketing authorisation holder: LILLY
- Local brand name: PROGESTERONE
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Progesterone on 1 November 1974
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 1 November 1974; FDA authorised it on 11 May 1978; FDA authorised it on 22 June 2009.
LILLY holds the US marketing authorisation.